Used primarily as a key intermediate in organic synthesis, especially in pharmaceutical manufacturing. It serves as a sulfonylating agent to introduce the 2-(morpholin-4-yl)ethanesulfonyl group into bioactive molecules. This modification enhances pharmacokinetic properties such as solubility and metabolic stability. Commonly employed in the development of enzyme inhibitors and receptor modulators, particularly in central nervous system and metabolic disorder research. Its morpholine ring contributes to favorable polarity and hydrogen bonding, improving target binding and drug-likeness. Also utilized in agrochemicals for designing active ingredients with improved efficacy and selectivity.